½ÃÀ庸°í¼­
»óǰÄÚµå
1463582

Áß³²¹ÌÀÇ ¼Ò Áø´Ü : ½ÃÀå ¿¹Ãø(2030³â) - ºÎ¹®º° ºÐ¼®

South & Central America Bovine Diagnostics Market Forecast to 2030 - Regional Analysis - by Product, Disease Type, and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 70 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Áß³²¹ÌÀÇ ¼Ò Áø´Ü(Bovine Diagnostics) ½ÃÀåÀº 2022³â 1¾ï 1,401¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 1¾ï 7,957¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. 2022-2030³âÀÇ CAGRÀº 5.8%·Î ÃßÁ¤µË´Ï´Ù.

¿ìÀ¯¹æ¿°ÀÇ ³ôÀº À¯Çà·ü°ú °æÁ¦Àû ¿µÇâÀÌ Áß³²¹ÌÀÇ ¼Ò Áø´Ü ½ÃÀåÀ» µÞ¹Þħ

¿ìÀ¯¹æ¿°Àº ¼¼°è ³ó¾÷ ºÎ¹®¿¡ ¸·´ëÇÑ °æÁ¦Àû ¼Õ½ÇÀ» ÃÊ·¡ÇÏ´Â ¼¼°è ¹®Á¦ÀÔ´Ï´Ù. À¯¹æ¿°Àº ÀÌȯ µ¿¹°ÀÇ ¿ìÀ¯ »ý»ê·®À» ³·Ãß°í Áö¼ÓÀûÀÎ ¼öÀÇÇÐ ÁöÃâÀ» À¯¹ßÇÏ¿© ³«³ó¾÷ Á¾»çÀÚÀÇ ¼öÀͼºÀ» °¨¼Ò½Ãŵ´Ï´Ù. Thermo Fisher ScientificÀÌ 2022³â 7¿ù¿¡ ¹ßÇ¥ÇÑ ÃßÁ¤¿¡ µû¸£¸é À¯¹æ¿°¿¡ ÀÇÇÑ ¼¼°èÀÇ ³«³ó »ê¾÷ÀÇ ¿¬°£ ÃÑ ºñ¿ëÀº 197¾ï-320¾ï ´Þ·¯ÀÔ´Ï´Ù.

2021³â 4¿ù¿¡ ¹ßÇ¥µÈ ¿¬±¸ ¡°Global and countrywide prevalence of subclinical and clinical mastitis in dairy cattle and buffaloes by systematic review and meta-analysis Àüü À¯º´·ü : ü°èÀû °ËÅä ¹× ¸ÞŸ ºÐ¼®¿¡ ÀÇÇÔ)¿¡ µû¸£¸é, 2011-2019³â »çÀÌ¿¡ Ç®¸µµÈ ÀáÀ缺 À¯¹æ¿°(SCM)°ú ÀÓ»ó¼º À¯¹æ¿°(CM)ÀÇ ¼¼°èÀû À¯º´·üÀº °¢°¢ 42%¿Í 15%¿´½À´Ï´Ù. À¯¹æ¿°ÀÇ À¯º´·üÀº À¯Á¦Ç° »ê¾÷¿¡¼­ À¯¹æ¿°ÀÇ ¿ª»ç°¡ ±æ±â ¶§¹®¿¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àü ¼¼°èÀÇ »ç½Ç°ú µ¥ÀÌÅÍ´Â ÀÓ»ó À¯¹æ¿°ÀÇ ³ôÀº À¯º´·üÀ» ³ªÅ¸³»¸ç, ÀÌ´Â ¼Ò Áø´Ü ¼ö¿ä¸¦ À¯¹ßÇÕ´Ï´Ù. ¶ÇÇÑ, °¢±¹ Á¤ºÎ°¡ µµÀÔÇϰí ÀÖ´Â °¨½Ã ÇÁ·Î±×·¥°ú ÀûÁ¤ °ü¸® ½Ã½ºÅÛÀÌ ¼Ò Áø´Ü ½ÃÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

Áß³²¹Ì ¼Ò Áø´Ü ½ÃÀå °³¿ä

Áß³²¹Ì ¼Ò Áø´Ü ½ÃÀåÀº ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª ¹× ±âŸ ³²¹Ì·Î ±¸ºÐµË´Ï´Ù. ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀº ÁÖ·Î ¼Ò Áø´Ü µµ±¸¿Í ±â¼ú Áøº¸, ±¸Á¦¿ª ¹× °áÇÙ±Õ Áõ°¡, ¼è°í±â¸¦ Æ÷ÇÔÇÑ ½ÄǰÀÇ Ç°Áú Çâ»óÀ» À§ÇÑ ¼Ò Áø´Ü Áõ°¡ µî ¿äÀο¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù. ºê¶óÁúÀº Áß³²¹ÌÀÇ ¼Ò Áø´Ü ½ÃÀåÀÇ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù. ºê¶óÁúÀº ¼¼°è Á¦ÀÏÀÇ Ãà»ê±¹À̸ç, ¼ÒÀÇ »çÀ°µÎ¼öµµ ¼¼°è Á¦ÀÏÀÔ´Ï´Ù. ¼¼°è Àα¸ Áõ°¡¿Í »ýȰ¼öÁØÀÇ Çâ»óÀº ¼¼°è ½ÄÀ° ¼ö¿ä¸¦ ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. µû¶ó¼­ °Ç°­ÇÑ °í±â¿¡ ´ëÇÑ ¼ö¿ä´Â ºê¶óÁú ¼Ò Áø´Ü ½ÃÀå ¼ºÀåÀ» °¡Á®¿É´Ï´Ù. Áø´Ü ±â¼úÀÇ ¹ßÀüÀ¸·Î ¼Ò ¹éÇ÷º´ ¹ÙÀÌ·¯½º(BLV)ÀÇ Áø´Ü°ú °èÅë ºÐ¼®ÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. Á¥¼ÒÀÇ BLV °¨¿°Àº ºê¶óÁú ºÏµ¿ºÎÀÇ Maranhao¿¡¼­ µÎµå·¯Á³À¸¸ç, 2022³â¿¡ óÀ½À¸·Î ü°èÀûÀÎ Ãß·ÐÀ¸·Î ÀÌ Áö¿ª¿¡¼­ À¯ÀüÀÚÇü 6ÀÌ ³ªÅ¸³µ½À´Ï´Ù. ÀÌ À¯ÀüÀÚÇüÀº ÀÌÀü¿¡ ºê¶óÁú Áß¼­ºÎ ¹× ³²µ¿ºÎ »ùÇÿ¡¼­ È®ÀÎµÈ À¯ÀüÀÚ ¼­¿­°ú ¿¬°üµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ¿Í °°ÀÌ 2022³â¿¡ BLV¿Í EBL Áø´ÜÀ» À§ÇÑ °³¹ß ³ë·ÂÀÌ °³½ÃµÊÀ¸·Î½á Á¶±â ´Ü°è¿¡ ÀÖ´Â °¨¿° »ç·Ê¿¡ ´ëÇÑ ¹éÇ÷º´ Ä¡·á ¿É¼ÇÀÇ ÁøÀüÀÌ ÃËÁøµÇ¾ú½À´Ï´Ù. ¹ßº´ ¼Ò ¹éÇ÷º´(EBL)Àº ¼Ò±º¿¡ ³Î¸® ºÐÆ÷ÇÏ´Â ¸¸¼º ¹ÙÀÌ·¯½º¼º ÁúȯÀ¸·Î ÀÓ»ó Áõ»óÀÌ ³ªÅ¸³ª±â±îÁö ¸î ³âÀÌ °É¸± ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ ¼ÒÀÇ À¯ÇàÀ» ¹æÁöÇϱâ À§ÇØ Áø´ÜÀ» ÅëÇØ ¼öÀÇ»ç º¸°Ç ´ç±¹°ú Ãà»ê ³ó¾÷ Á¾»çÀÚ°¡ »çÀü ´ëÃ¥À» ÃëÇÒ ¼ö ÀÖ½À´Ï´Ù.

Áß³²¹Ì ¼Ò Áø´Ü ½ÃÀå ¸ÅÃâ ¹× ¿¹Ãø(-2030³â)(±Ý¾×)

Áß³²¹Ì ¼Ò Áø´Ü ½ÃÀå ¼¼ºÐÈ­

Áß³²¹Ì ¼Ò Áø´Ü ½ÃÀåÀº Á¦Ç°, Áúº´ À¯Çü, ÃÖÁ¾ »ç¿ëÀÚ, ±¹°¡·Î ±¸ºÐµË´Ï´Ù.

Á¦Ç°º°·Î Áß³²¹ÌÀÇ ¼Ò Áø´Ü ½ÃÀåÀº ¸é¿ª°ËÁ¤ ŰƮ, PCR ½Ã¾à ¹× ŰƮ, Ç÷±¸ÀÀÁý ¾ïÁ¦(HI) ºÐ¼®, ±âŸ Á¦Ç°À¸·Î ±¸ºÐµË´Ï´Ù. 2022³â Áß³²¹Ì ¼è°í±â Áø´Ü ½ÃÀå¿¡¼­´Â ¸é¿ªºÐ¼® ŰƮ ºÎ¹®ÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

Áúº´ À¯Çüº°·Î º¸¸é Áß³²¹ÌÀÇ ¼Ò Áø´Ü ½ÃÀåÀº ¼Ò ¹ÙÀÌ·¯½º¼º ¼³»ç(BVD), ¼Ò °áÇÙ(TB), ¿ìÀ¯¹æ¿°, ±¸Á¦¿ª(FMD), ±âŸ Áúº´ À¯ÇüÀ¸·Î ±¸ºÐµË´Ï´Ù. 2022³â Áß³²¹Ì ¼è°í±â Áø´Ü ½ÃÀå¿¡¼­´Â ¿ìÀ¯¹æ¿° ºÎ¹®ÀÌ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î º¸¸é Áß³²¹Ì ¼Ò Áø´Ü ½ÃÀåÀº µ¿¹° º´¿ø, µ¿¹° Ŭ¸®´Ð ¹× ±âŸ ÃÖÁ¾ »ç¿ëÀÚ·Î ±¸ºÐµË´Ï´Ù. 2022³â Áß³²¹Ì ¼Ò Áø´Ü ½ÃÀå¿¡¼­´Â µ¿¹° º´¿ø ºÎ¹®ÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

±¹°¡º°·Î º¸¸é Áß³²¹Ì ¼Ò Áø´Ü ½ÃÀåÀº ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª ¹× ±âŸ ³²¹Ì·Î ±¸ºÐµË´Ï´Ù. 2022³â Áß³²¹Ì ¼Ò Áø´Ü ½ÃÀåÀº ºê¶óÁúÀÌ µ¶Á¡Çß½À´Ï´Ù.

Idexx Laboratories Inc, bioMerieux SA, Innovative Diagnostics SAS, Neogen Corp, Thermo Fisher Scientific Inc µîÀÌ Áß³²¹ÌÀÇ ¼Ò Áø´Ü ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â ´ë±â¾÷ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

  • ´ë»ó ¹üÀ§
  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç

Á¦4Àå Áß³²¹ÌÀÇ ¼Ò Áø´Ü ½ÃÀå : ÁÖ¿ä »ê¾÷ ¿ªÇÐ

  • ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¿ìÀ¯¹æ¿°ÀÇ ³ôÀº À¯º´·ü°ú °æÁ¦Àû ¿µÇâ
    • Á¦Ç°Ãâ½Ã¼ö Áõ°¡
  • ÁÖ¿ä ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼öÀÇÇÐ ¿¬±¸¿¡ À־ ¼÷·Ã Àü¹®°¡ ºÎÁ·
  • ÁÖ¿ä ½ÃÀå ±âȸ
    • ¼Ò°áÇÙÀÇ ³ôÀº À¯º´·ü
  • ÇâÈÄ µ¿Çâ
    • µ¥ÀÌÅÍ ºÐ¼®°ú ÀΰøÁö´É(AI)ÀÇ ÅëÇÕ
  • ¿µÇ⠺м®

Á¦5Àå ¼Ò Áø´Ü ½ÃÀå : Áß³²¹Ì ½ÃÀå ºÐ¼®

  • Áß³²¹ÌÀÇ ¼Ò Áø´Ü ½ÃÀå ¼öÀÍ(2022-2030³â)

Á¦6Àå Áß³²¹Ì ¼Ò Áø´Ü ½ÃÀå ¸ÅÃâ ¹× ¿¹Ãø(-2030³â) : Á¦Ç°º°

  • ¼Ò°³
  • Áß³²¹Ì ¼Ò Áø´Ü ½ÃÀå(2022³â, 2030³â) : Á¦Ç°º° ¸ÅÃâ Á¡À¯À²(%)
  • ¸é¿ª ÃøÁ¤ ŰƮ
  • PCR ŰƮ
  • Ç÷±¸ ÀÀÁý ¾ïÁ¦(HI) ºÐ¼®
  • ±âŸ

Á¦7Àå Áß³²¹Ì ¼Ò Áø´Ü ½ÃÀå ¸ÅÃâ ¹× ¿¹Ãø(-2030³â) : Áúº´ À¯Çüº°

  • ¼Ò°³
  • Áß³²¹Ì ¼Ò Áø´Ü ½ÃÀå(2022³â, 2030³â) : Áúȯ À¯Çüº° ¸ÅÃâ Á¡À¯À²(%)
  • ¼Ò¹ÙÀÌ·¯½º¼º ¼³»ç(BVD)
  • ¼Ò°áÇÙ(TB)
  • ¿ìÀ¯¹æ¿°
  • ±¸Á¦¿ª(FMD)
  • ±âŸ Áúº´

Á¦8Àå Áß³²¹Ì ¼Ò Áø´Ü ½ÃÀå ¸ÅÃâ ¹× ¿¹Ãø(-2030³â) : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼Ò°³
  • Áß³²¹Ì ¼Ò Áø´Ü ½ÃÀå(2022³â, 2030³â) : ÃÖÁ¾ »ç¿ëÀÚº° ¸ÅÃâ Á¡À¯À²(%)
  • µ¿¹°º´¿ø
  • µ¿¹° Ŭ¸®´Ð
  • ±âŸ

Á¦9Àå Áß³²¹ÌÀÇ ¼Ò Áø´Ü ½ÃÀå : ±¹°¡º° ºÐ¼®

  • ºê¶óÁú
  • ¾Æ¸£ÇîÆ¼³ª
  • ±âŸ Áß³²¹Ì

Á¦10Àå ¼Ò Áø´Ü ½ÃÀå : »ê¾÷ Á¤¼¼

  • ¼Ò°³
  • ¼ºÀå Àü·«

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Idexx Laboratories Inc
  • Thermo Fisher Scientific Inc
  • Innovative Diagnostics SAS
  • Neogen Corp
  • bioMerieux SA

Á¦12Àå ºÎ·Ï

LYJ

The South & Central America bovine diagnostics market is expected to grow from US$ 114.01 million in 2022 to US$ 179.57 million by 2030. It is estimated to grow at a CAGR of 5.8% from 2022 to 2030.

High Prevalence and Economic Impact of Bovine Mastitis Fuels South & Central America Bovine Diagnostics Market

Bovine mastitis is a global concern that incurs huge economic losses to the global agriculture sector. Mastitis results in lowered milk production in affected animals and causes continuous veterinary expenses, resulting in reduced profitability for dairy farmers. According to the estimates published by Thermo Fisher Scientific in July 2022, the total annual cost to the global dairy industry caused by mastitis is between US$ 19.7 billion to US$ 32 billion.

According to the study "Global and countrywide prevalence of subclinical and clinical mastitis in dairy cattle and buffaloes by systematic review and meta-analysis," published in April 2021, the global pooled prevalence of subclinical mastitis (SCM) and clinical mastitis (CM) were 42% and 15%, respectively, during 2011-2019. The prevalence of mastitis is expected to increase due to the prolonged history of the disease in the dairy industry. The facts and data from across the world indicate the high prevalence of clinical mastitis, which triggers the demand for bovine diagnostics. Moreover, surveillance programs and good management systems introduced by governments in different countries support the bovine diagnostics market.

South & Central America Bovine Diagnostics Market Overview

The bovine diagnostics market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in this region is mainly driven by the factors such as advancements in bovine diagnostics tools and technologies, increasing incidences of foot and mouth diseases and bTB, and a rise in bovine diagnostics to enhance the quality of food products containing bovine meat. Brazil counts for the largest share of the bovine diagnostic market in South & Central America. Brazil is the world's leading livestock country, with the largest number of cattle grown. The growth of the world's population and improvements in living standards boost the demand for meat across the world. Therefore, the demand for healthy meats results in the growth of the bovine diagnostics market in Brazil. Technological progress in diagnostics has enabled the diagnosis and phylogenetic analysis of bovine leukemia virus (BLV). The BLV infection in dairy cattle was evident in Maranhao, Northeastern Brazil, and for the first time in 2022, phylogenetic inferences showed genotype 6 in this region. This genotype is related to gene sequences previously identified in samples from central-western and southeastern Brazil. Thus, the development efforts for BLV and EBL diagnosis were initiated in 2022, which has fueled progress in leukemia treatment options for the cases of infections that are in an early stage. Enzootic bovine leukosis (EBL) is a chronic viral disease widely distributed in cattle herds and may take several years to manifest clinical signs. Thus, to prevent the epidemic in cattle, the diagnosis would allow veterinary health authorities and animal farmers to take preliminary actions.

South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Bovine Diagnostics Market Segmentation

The South & Central America bovine diagnostics market is segmented into product, disease type, end user, and country.

Based on product, the South & Central America bovine diagnostics market is segmented into immunoassay kits, PCR reagents & kits, hemagglutination inhibition (HI) assay, and other products. The immunoassay kits segment held the largest share of the South & Central America bovine diagnostics market in 2022.

Based on disease type, the South & Central America bovine diagnostics market is segmented into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and other disease types. The bovine mastitis segment held the largest share of the South & Central America bovine diagnostics market in 2022.

Based on end user, the South & Central America bovine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and other end-users. The veterinary hospitals segment held the largest share of the South & Central America bovine diagnostics market in 2022.

Based on country, the South & Central America bovine diagnostics market is segmented int o Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America bovine diagnostics market in 2022.

Idexx Laboratories Inc, bioMerieux SA, Innovative Diagnostics SAS, Neogen Corp, and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America bovine diagnostics market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Bovine Diagnostics Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 High Prevalence and Economic Impact of Bovine Mastitis
    • 4.1.2 Increasing Number of Product Launches
  • 4.2 Key Market Restraints:
    • 4.2.1 Lack of Skilled Professionals in Veterinary Research
  • 4.3 Key Market Opportunities:
    • 4.3.1 High Prevalence of Bovine Tuberculosis
  • 4.4 Future Trends
    • 4.4.1 Integration of Data Analytics and Artificial Intelligence (AI)
  • 4.5 Impact Analysis:

5. Bovine Diagnostics Market - South & Central America Market Analysis

  • 5.1 South & Central America Bovine Diagnostics Market Revenue (US$ Mn), 2022 - 2030

6. South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 - by Product

  • 6.1 Overview
  • 6.2 South & Central America Bovine Diagnostics Market Revenue Share, by Product 2022 & 2030 (%)
  • 6.3 Immunoassay Kits
    • 6.3.1 Overview
    • 6.3.2 Immunoassay Kits: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 PCR Kits
    • 6.4.1 Overview
    • 6.4.2 PCR Kits: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Hemagglutination Inhibition (HI) Assay
    • 6.5.1 Overview
    • 6.5.2 Hemagglutination Inhibition (HI) Assay: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Other Products
    • 6.6.1 Overview
    • 6.6.2 Other Products: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 - by Disease Type

  • 7.1 Overview
  • 7.2 South & Central America Bovine Diagnostics Market Revenue Share, by Disease Type 2022 & 2030 (%)
  • 7.3 Bovine Viral Diarrhea (BVD)
    • 7.3.1 Overview
    • 7.3.2 Bovine Viral Diarrhea (BVD): South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Bovine Tuberculosis (TB)
    • 7.4.1 Overview
    • 7.4.2 Bovine Tuberculosis (TB): South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Bovine Mastitis
    • 7.5.1 Overview
    • 7.5.2 Bovine Mastitis: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Foot and Mouth Disease (FMD)
    • 7.6.1 Overview
    • 7.6.2 Foot and Mouth Disease (FMD): South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Other Disease Types
    • 7.7.1 Overview
    • 7.7.2 Other Disease Types: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 - by End User

  • 8.1 Overview
  • 8.2 South & Central America Bovine Diagnostics Market Revenue Share, by end user 2022 & 2030 (%)
  • 8.3 Veterinary Hospitals
    • 8.3.1 Overview
    • 8.3.2 Veterinary Hospitals: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Veterinary Clinics
    • 8.4.1 Overview
    • 8.4.2 Veterinary Clinics: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Other End-Users
    • 8.5.1 Overview
    • 8.5.2 Other End-Users: South & Central America Bovine Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Bovine Diagnostics Market - Country Analysis

  • 9.1 South & Central America Bovine Diagnostics Market, Revenue and Forecast to 2030
    • 9.1.1 Overview
      • 9.1.1.1 South & Central America Bovine Diagnostics Market, by Country
      • 9.1.1.2 Brazil
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 Brazil: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.2.3 Brazil: South & Central America Bovine Diagnostics Market, by Product
        • 9.1.1.2.4 Brazil: South & Central America Bovine Diagnostics Market, by Disease Type
        • 9.1.1.2.5 Brazil: South & Central America Bovine Diagnostics Market, by End User
      • 9.1.1.3 Argentina
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 Argentina: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.3.3 Argentina: South & Central America Bovine Diagnostics Market, by Product
        • 9.1.1.3.4 Argentina: South & Central America Bovine Diagnostics Market, by Disease Type
        • 9.1.1.3.5 Argentina: South & Central America Bovine Diagnostics Market, by End User
      • 9.1.1.4 Rest of South & Central America
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 Rest of South & Central America: South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.4.3 Rest of South & Central America: South & Central America Bovine Diagnostics Market, by Product
        • 9.1.1.4.4 Rest of South & Central America: South & Central America Bovine Diagnostics Market, by Disease Type
        • 9.1.1.4.5 Rest of South & Central America: South & Central America Bovine Diagnostics Market, by End User

10. Bovine Diagnostics Market - Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies
    • 10.2.1 Overview

11. Company Profiles

  • 11.1 Idexx Laboratories Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Thermo Fisher Scientific Inc
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Innovative Diagnostics SAS
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Neogen Corp
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 bioMerieux SA
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦